Matthew Figley, Ph.D. - Publications

2010-2012 Developmental Biology University of Pennsylvania, Philadelphia, PA, United States 
 2012-2015 Genetics Stanford University, Palo Alto, CA 
 2015- Developmental Biology Washington University, Saint Louis, St. Louis, MO 

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Figley MD, DiAntonio A. The SARM1 axon degeneration pathway: control of the NAD metabolome regulates axon survival in health and disease. Current Opinion in Neurobiology. 63: 59-66. PMID 32311648 DOI: 10.1016/j.conb.2020.02.012  1
2020 Sasaki Y, Engber TM, Hughes RO, Figley MD, Wu T, Bosanac T, Devraj R, Milbrandt J, Krauss R, DiAntonio A. cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axons. Experimental Neurology. 113252. PMID 32087251 DOI: 10.1016/j.expneurol.2020.113252  1
2015 Figley MD, Gitler AD. Neurodegeneration: A Leg Up on TDP-43. Current Biology : Cb. 25: R728-31. PMID 26294190 DOI: 10.1016/j.cub.2015.06.064  1
2014 Figley MD, Bieri G, Kolaitis RM, Taylor JP, Gitler AD. Profilin 1 associates with stress granules and ALS-linked mutations alter stress granule dynamics. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 8083-97. PMID 24920614 DOI: 10.1523/JNEUROSCI.0543-14.2014  1
2014 Figley MD, Thomas A, Gitler AD. Evaluating noncoding nucleotide repeat expansions in amyotrophic lateral sclerosis. Neurobiology of Aging. 35: 936.e1-4. PMID 24269018 DOI: 10.1016/j.neurobiolaging.2013.09.024  1
2013 Figley MD, Gitler AD. Yeast genetic screen reveals novel therapeutic strategy for ALS. Rare Diseases (Austin, Tex.). 1: e24420. PMID 25002991 DOI: 10.4161/rdis.24420  1
2012 Armakola M, Higgins MJ, Figley MD, Barmada SJ, Scarborough EA, Diaz Z, Fang X, Shorter J, Krogan NJ, Finkbeiner S, Farese RV, Gitler AD. Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease models. Nature Genetics. 44: 1302-9. PMID 23104007 DOI: 10.1038/ng.2434  1
2010 Bonneh-Barkay D, Zagadailov P, Zou H, Niyonkuru C, Figley M, Starkey A, Wang G, Bissel SJ, Wiley CA, Wagner AK. YKL-40 expression in traumatic brain injury: an initial analysis. Journal of Neurotrauma. 27: 1215-23. PMID 20486806 DOI: 10.1089/neu.2010.1310  1
Show low-probability matches.